Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Regulation of Hematopoietic Stem Cells01:01

Regulation of Hematopoietic Stem Cells

3.4K
All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
3.4K
Cirrhosis II: Pathophysiology01:24

Cirrhosis II: Pathophysiology

34
Cirrhosis is a progressive chronic liver injury caused by prolonged inflammation, excessive fibrotic remodeling, and impaired regeneration. Over time, repeated hepatic insults disrupt the liver’s architecture and function, leading to reduced blood flow, impaired bile drainage, and diminished metabolic capacity.Pathophysiology of cirrhosisCirrhosis arises from three main responses to chronic liver damage: inflammation, immune activation, and hepatocyte death. These processes lead to...
34
Differentiation of Common Myeloid Progenitor Cells01:15

Differentiation of Common Myeloid Progenitor Cells

3.1K
Common myeloid progenitors (CMPs) are oligopotent cells that can differentiate into granulocytes and macrophages. Granulocytes and macrophages are essential for protecting the body against bacterial, viral, or fungal infections. They migrate from the bone marrow into the circulating blood to reach specific tissue sites where they differentiate and help in immune surveillance. However, they survive only for a few days and must be continuously made available to the organism to maintain a robust...
3.1K
Cirrhosis I: Introduction01:23

Cirrhosis I: Introduction

26
Cirrhosis is a chronic, irreversible liver disease characterized by the widespread replacement of healthy liver tissue with fibrotic scar tissue and the formation of regenerative nodules.Etiology of cirrhosisCirrhosis results from sustained liver injury that triggers progressive fibrosis and structural remodeling. The underlying causes are diverse, encompassing common and less frequent clinical conditions. Regardless of the origin, all causes lead to chronic inflammation, hepatocyte loss, and...
26
Liver Regeneration01:24

Liver Regeneration

4.1K
The liver is an important organ in vertebrates that plays an essential role in metabolism. It is also responsible for storing and redistributing nutrients such as carbohydrates, fats, and vitamins in the body. Additionally, the liver releases bile salts which are critical for digesting food and eliminating toxic metabolites from the body.
Cells of Liver
The liver comprises four major types of cells— hepatocytes, stellate, Kupffer, and sinusoidal endothelial cells. The hepatocytes are...
4.1K
Hepatitis01:25

Hepatitis

80
Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver.
80

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Selenium-Containing 1,4-Naphthoquinone Derivatives Trigger Reactive Oxygen Species and Apoptosis in Triple-Negative Breast Cancer Cells.

Drug development research·2026
Same author

Handheld hyperspectral imaging dataset of annual sowthistle and little mallow under abiotic stress for machine learning.

Data in brief·2026
Same author

Microbial dysbiosis in metabolic disorders: linking epigenomic regulation and pathological mechanisms.

Drug discovery today·2026
Same author

Targeting bacitracin resistance-associated histidine kinase (BraS) in MRSA with isatin and indazole derivatives.

Scientific reports·2026
Same author

Laryngeal leishmaniasis presenting with hoarseness in a child from the highland of Nepal: A rare diagnostic challenge.

IDCases·2026
Same author

CerS2 Is a Druggable Target in Triple-Negative Breast Cancer.

Molecular cancer therapeutics·2026

Related Experiment Video

Updated: Apr 28, 2026

Induction of Alloantigen-specific Anergy in Human Peripheral Blood Mononuclear Cells by Alloantigen Stimulation with Co-stimulatory Signal Blockade
11:55

Induction of Alloantigen-specific Anergy in Human Peripheral Blood Mononuclear Cells by Alloantigen Stimulation with Co-stimulatory Signal Blockade

Published on: March 14, 2011

17.2K

Granulocyte colony-stimulating factor in severe alcoholic hepatitis: a randomized pilot study.

Virendra Singh1, Arun K Sharma1, R Lakshmi Narasimhan2

  • 1Department of Hepatology, Post Graduate Institute of Medical Education and Research (PGIMER), Chandigarh, India.

The American Journal of Gastroenterology
|June 18, 2014
PubMed
Summary

Granulocyte colony-stimulating factor (G-CSF) treatment significantly increased stem cell mobilization and improved survival in patients with severe alcoholic hepatitis. This G-CSF therapy enhanced liver function and showed a marked survival benefit at 90 days.

More Related Videos

Establishment of the Dual Humanized TK-NOG Mouse Model for HIV-associated Liver Pathogenesis
10:12

Establishment of the Dual Humanized TK-NOG Mouse Model for HIV-associated Liver Pathogenesis

Published on: September 11, 2019

7.9K
Histological Analyses of Acute Alcoholic Liver Injury in Zebrafish
10:45

Histological Analyses of Acute Alcoholic Liver Injury in Zebrafish

Published on: May 25, 2017

14.7K

Related Experiment Videos

Last Updated: Apr 28, 2026

Induction of Alloantigen-specific Anergy in Human Peripheral Blood Mononuclear Cells by Alloantigen Stimulation with Co-stimulatory Signal Blockade
11:55

Induction of Alloantigen-specific Anergy in Human Peripheral Blood Mononuclear Cells by Alloantigen Stimulation with Co-stimulatory Signal Blockade

Published on: March 14, 2011

17.2K
Establishment of the Dual Humanized TK-NOG Mouse Model for HIV-associated Liver Pathogenesis
10:12

Establishment of the Dual Humanized TK-NOG Mouse Model for HIV-associated Liver Pathogenesis

Published on: September 11, 2019

7.9K
Histological Analyses of Acute Alcoholic Liver Injury in Zebrafish
10:45

Histological Analyses of Acute Alcoholic Liver Injury in Zebrafish

Published on: May 25, 2017

14.7K

Area of Science:

  • Hepatology
  • Stem Cell Biology
  • Hematology

Background:

  • Severe alcoholic hepatitis presents a significant short-term mortality risk.
  • Bone marrow-derived stem cells are crucial for hepatic regeneration.
  • Investigating novel therapeutic strategies to improve outcomes in alcoholic hepatitis is essential.

Purpose of the Study:

  • To evaluate the efficacy of granulocyte colony-stimulating factor (G-CSF) in mobilizing bone marrow-derived stem cells.
  • To assess the impact of G-CSF on hepatic regeneration and liver function.
  • To determine the effect of G-CSF on short-term survival in severe alcoholic hepatitis patients.

Main Methods:

  • A randomized open study involving 46 patients with severe alcoholic hepatitis.
  • Group A received standard medical therapy (SMT) plus G-CSF; Group B received SMT alone.
  • Assessment of CD34(+) cell mobilization, liver function scores (CTP, MELD, mDF), and 90-day survival.

Main Results:

  • G-CSF therapy led to a statistically significant increase in peripheral blood CD34(+) cells.
  • Patients treated with G-CSF showed significant improvements in CTP, MELD, and mDF scores.
  • A marked improvement in 90-day survival was observed in the G-CSF group (78.3% vs. 30.4%).

Conclusions:

  • G-CSF is a safe and effective agent for mobilizing hematopoietic stem cells in severe alcoholic hepatitis.
  • G-CSF treatment significantly improves liver function and enhances survival rates.
  • G-CSF represents a promising therapeutic option for patients with severe alcoholic hepatitis.